Actively Recruiting

Phase 2
Age: 18Years - 80Years
MALE
NCT06220188

PSMA-RLT in Biochemically Recurrent PCa

Led by Medical University of Vienna · Updated on 2024-02-13

20

Participants Needed

1

Research Sites

154 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prospective single-center one-arm phase II study in patients with prostate cancer and confirmed biochemical recurrence (BCR) with PSA of ≥ 0.2 ng/ml after radical prostatectomy (RP) or PSA \> nadir + 2ng/ml after radiotherapy (RT) but not radio-morphological local recurrence after primary therapy with curative intent receive systemic therapy with only 2 cycles of highly standardized (3 GBq in first cycle and 6 GBq in the second cycle) PSMA-RLT at 6-week intervals.

CONDITIONS

Official Title

PSMA-RLT in Biochemically Recurrent PCa

Who Can Participate

Age: 18Years - 80Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with biochemical recurrence after radical prostatectomy and radiotherapy with a PSA doubling-time of 4 months
  • No hormonal therapy within the last 12 months or recovered testosterone levels
  • PSMA PET negative result for local recurrence; distant metastases allowed (cN0, cM0/cM1)
  • Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1
  • Adequate bone marrow reserve: WBC 1.5 x 10^9/L, Platelets 100 x 10^9/L, Haemoglobin 9 g/dL
  • Adequate renal function with eGFR 50 mL/min/1.73m2 and Albumin 2.5 g/dL
  • Ability to sign Informed Consent Form
Not Eligible

You will not qualify if you...

  • Participation in any other interventional trial
  • Severe oncological and medical conditions with life expectancy under one year
  • Clinically relevant somatic or psychiatric diseases interfering with study objectives
  • Complete urinary out-flow obstruction or severe unmanageable urinary incontinence

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Medical University of Vienna

Vienna, Austria, 1090

Actively Recruiting

Loading map...

Research Team

S

Sazan Rasul, PhD

CONTACT

S

Shahrokh F. Shariat, Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here